Key selected papers frequently quoted or needed to be reviewed are linked from this page to the original PDF.
Papers are listed under diagnosis categories.
If link to HTLM version of the paper is preferred to obtain powerpoint or other graphic information for presentation, please let me know.
All the Blood Journal Collection “How I Treat” linked here
ALL
Common Treatment Regimens
BFM Regimens. For adolescents and young adults under 30. Blood 2008.pdf.
GRAALL Regimen Pediatric inspired regimen, toxicity does not allow to be use in older than 45. JCO 2009 GRAAL Trial.pdf.
CALGB study 8811 For adults ver 30 years old
AML
Most recent review of AML Review Blood 2010.pdf
This paper is an argument to intesify the standard induction regimen for AML:
Anthracycline High Dose in AML NEJM 2009.pdf
In individuals aged 60 t0 65 a better result was seen intensifying the daunorubicin dose too, but not in the older population:
HD Daunorubicine AML Old NEJM 2009.pdf
APL
The PETHEMA 2005 Treatment Adapted Therapy, published ASH Abstract 138, 2008:
Risk-Adapted Tx of APL Results of the PETHEMA LPA 2005.doc
PETHEMA Tx for Elderly APL Blood 2004.pdf
APL Induction with ATO single agent.pdf
Blood -- Use of ATRA ATO as an alternative .webarchive
Aplastic Anemia
AA Pathogenesis and Treatment. ASH Educational Book 2007, by Bacigalupo.pdf
Multiple Myeloma
Induction
VTD ASH 2008 Cavo Abstract.doc
LMWH ASA or Warfarin Prohylaxis for Myeloma.doc
Lenalid Bort Dex for MM Blood 2010.pdf
Maintenance
Maintenance Thalidomide in MM.pdf
CLL
Phase III bendamustine vs chlorambucil CLL JCO 2009.pdf
Pentostatin Cytoxan and R for untreated CLL Blood 2007.pdf
NHL
Mantle Cell Lymphoma (MCL)
Review Paper from a Blood issue from 2009, they cover treatment recommendations for all stages, ages and PS of patients with MCL.
European MCL HSCT Randomized Trial Blood 2005.pdf
This European trial is the only prospective randomized trial using Auto HSCT in first CR in MCL.
Nordic Trial HSCT for Mantle Cell NHL 2008 Blood.pdf
Prospective Phase II trial of Auto HSCT for MCL in 160 consecutive patients, then compared with historical controls.
Retrospective review of results of MCL patients treated at MD Anderson with HSCT in first CR, second CR and with Nonmyeloablative allogeneic transplant.
QI in Health Care
Productivity Assessment of Midlevels report in Journal of Oncology Practice
http://jop.ascopubs.org/content/8/3/167.full
Dartmouth Institute web page:
http://content.nejm.org/cgi/content/full/360/9/849
http://www.dartmouthatlas.org/atlases/Spending_Brief_022709.pdf
http://www.dartmouthatlas.org/interactive_map.shtm
The Dartmouth Atlas Project
http://www.dartmouthatlas.org/
Quality Management Conference at Mayo Clinic, September 28-29, 2009.
